Amryt Pharma plc (LON:AMYT – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 143 ($1.80) and traded as low as GBX 143 ($1.80). Amryt Pharma shares last traded at GBX 143 ($1.80), with a volume of 90,727 shares trading hands.
Amryt Pharma Stock Performance
The company has a market cap of £457.11 million and a price-to-earnings ratio of -4.33. The stock’s fifty day simple moving average is GBX 143 and its two-hundred day simple moving average is GBX 143. The company has a debt-to-equity ratio of 66.05, a quick ratio of 1.14 and a current ratio of 1.80.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Featured Stories
- Five stocks we like better than Amryt Pharma
- Health Care Stocks Explained: Why You Might Want to Invest
- AMD is Down 35%. Now is the Time to Buy the Dip
- Where Do I Find 52-Week Highs and Lows?
- Amazon Stands Tall: New Highs Are in Sight
- What Are Dividends? Buy the Best Dividend Stocks
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
